The clinical significance of blood‐contaminated midtrimester amniocentesis

M. Ron*, T. Cohen, H. Yaffe, Y. Beyth

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Abstract. In 706 midtrimester amniocenteses, 180 (25.5%) samples yielded blood‐stained amniotic fluid (macroscopically and microscopically), 152 (21.5%) contained maternal blood, 28 (3.9%) fetal blood and 8 samples contained both maternal and fetal blood. In the 180 cases of bloody midtrimester amniocentesis, the abortion rate was 6.6% when maternal blood was found and 14.3% when fetal blood was aspirated, compared with 1.7% in controls. The amount of blood drawn did not alter pregnancy outcome. The percentage of bloody amniotic fluid in amniocenteses performed before the 16th week of pregnancy was much higher (36.7%) than during and after the 16th week of pregnancy (22%). Midtrimester amniocentesis should therefore be avoided before the 16th week of pregnancy. 1982 Acta Obstet Gynecol Scand

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalActa Obstetricia et Gynecologica Scandinavica
Volume61
Issue number1
DOIs
StatePublished - Jan 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'The clinical significance of blood‐contaminated midtrimester amniocentesis'. Together they form a unique fingerprint.

Cite this